Clinical Trials Browser

Phase 2 × Solid Tumor × sacituzumab govitecan × Clear all

NCT05119907 2025-11-17

Study of Sacituzumab Govitecan in Patients With Solid Tumor

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor